COSMED K5 Validation and Reliability Study
K5
Validity and Reliability of the K5 Wearable Metabolic System During High-Intensity Treadmill Testing in Healthy, Young Adults
1 other identifier
interventional
34
1 country
1
Brief Summary
To determine the validity of the K5 metabolic system breath-by-breath analysis setting during a high intensity treadmill running protocol compared to the criterion ParvoMedics TrueOne® 2400 automated metabolic gas analysis system. To determine the test-retest reliability of the K5 metabolic system breath-by-breath analyzer during a high intensity treadmill protocol (Bruce Protocol).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2021
CompletedStudy Start
First participant enrolled
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedJanuary 22, 2025
October 1, 2024
1.9 years
November 17, 2021
January 20, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Oxygen consumption (VO2), mL/min
Using metabolic cart, VO2 will be recorded.
At first assessment, during week one.
Oxygen consumption (VO2), mL/min
Using metabolic cart, VO2 will be recorded.
At second assessment, during week two.
Oxygen consumption (VO2), mL/min
Using metabolic cart, VO2 will be recorded.
At third assessment, during week three.
Carbon dioxide production (VCO2), mL/min
Using metabolic cart, VCO2 will be recorded.
At first assessment, during week one.
Carbon dioxide production (VCO2), mL/min
Using metabolic cart, VCO2 will be recorded.
At second assessment, during week two.
Carbon dioxide production (VCO2), mL/min
Using metabolic cart, VCO2 will be recorded.
At third assessment, during week three.
Secondary Outcomes (21)
Respiratory Exchange Ratio (RER)
At first assessment, during week one.
Respiratory Exchange Ratio (RER)
At second assessment, during week two.
Respiratory Exchange Ratio (RER)
At third assessment, during week three.
Minute Ventilation, L/min
At first assessment, during week one.
Minute Ventilation, L/min
At second assessment, during week two.
- +16 more secondary outcomes
Study Arms (2)
COSMED K5 CPET
EXPERIMENTALParticipants in this arm will complete the CPET using the COSMED K5 wearable metabolic system at first visit and the ParvoMedics TrueOne® 2400 automated metabolic gas analysis system at second visit.
ParvoMedics CPET
ACTIVE COMPARATORParticipants in this arm will complete the CPET using the ParvoMedics TrueOne® 2400 automated metabolic gas analysis system at first visit and the COSMED K5 wearable metabolic system at second visit.
Interventions
In this randomized crossover trial of eligible adults, we will compare peak measurements of oxygen consumption (VO2) and carbon dioxide production (VCO2) during three maximal cardiopulmonary stress exercise tests (CPET), each seven to ten days apart. Subjects will be randomized into either the K5 or ParvoMedics (PM) group for their first CPET using a 1:1 randomization scheme and will serve as their own control in the subsequent test seven to ten days after the previous one. After both a K5 and a PM CPETs have been completed, the participants will complete an additional K5 CPET for test-retest reliability. A within-subjects analysis will be performed.
Eligibility Criteria
You may qualify if:
- years of age
You may not qualify if:
- Pregnancy
- Children
- Inmates
- Neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise or conditions preventing cooperation
- Contraindications to Symptom-limited Maximal Exercise Testing
- Metabolic disease
- Pacemakers/Implantable devices
- Supplemental Oxygen use
- Diagnosis of severe arterial hypertension
- Uncontrolled asthma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor Scott and White Sports Therapy and Research
Frisco, Texas, 75034, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Center Director - The STAR at Frisco
Study Record Dates
First Submitted
November 17, 2021
First Posted
December 6, 2021
Study Start
November 29, 2021
Primary Completion
October 10, 2023
Study Completion
October 10, 2023
Last Updated
January 22, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share